Abstract
The global rise in terrorism has increased the risk of radiological events aimed at creating chaos and destabilization, although they may cause relatively limited number of immediate casualties. We have proposed that a self-administered test would be valuable for initial triage following terrorist use of nuclear/radiological devices. The urine proteome may be a useful source of the biomarkers required for developing such a test. We have developed and extensively used a rat model to study the acute and late effect of total body (TBI) and partial body irradiation on critical organ systems. This model has proven valuable for correlating the structural and functional effects of radiation with molecular changes. Results show that nephron segments differ with regard to their sensitivity and response to ionizing radiation. The urine proteome was analyzed using LC-MS/MS at 24 h after TBI or local kidney irradiation using a 10 Gy single dose of X rays. LC-MS/MS data were analyzed and grouped under Gene Ontology categories Cellular Localization, Molecular Function and Biological Process. We observed a decrease in urine protein/creatinine ratio that corroborated with decreased spectral counts for urinary albumin and other major serum proteins. Interestingly, TBI caused greater decline in urinary albumin than local kidney irradiation. Analysis of acute-phase response proteins and markers of acute kidney injury showed increased urinary levels of cystatin superfamily proteins and alpha-1-acid glycoprotein. Among proteases and protease inhibitors, levels of Kallikrein 1-related peptidase b24, precursor and products of chymotrypsin-like activity, were noticeably increased. Among the amino acids that are susceptible to oxidation by free radicals, oxidized histidine levels were increased following irradiation. Our results suggest that proteomic analysis of early changes in urinary proteins will identify biomarkers for developing a self-administered test for radiation biodosimetry.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
National Research Council (2009) Assessing medical preparedness to respond to a terrorist nuclear event: workshop report. The National Academy Press, Washington, DC
Sarin R (2011) Chernobyl, Fukushima, and beyond: a health safety perspective. J Cancer Res Ther 7(2):109–111
National Council on Radiation Protection and Measurements (2001) Management of terrorist events involving radioactive material. NCRP report no. 138, Bethesda
Swartz HM, Flood AB, Gougelet RM, Rea ME, Nicolalde RJ, Williams BB (2010) A critical assessment of biodosimetry methods for large-scale incidents. Health Phys 98(2):95–108
Lenarczyk M, Cohen EP, Fish BL, Irving AA, Sharma M, Driscoll CD et al (2009) Chronic oxidative stress as a mechanism for radiation nephropathy. Radiat Res 171(2):164–172
Moulder JE, Cohen EP, Fish BL (2011) Captopril and losartan for mitigation of renal injury caused by single-dose total body irradiation. Radiat Res 175(1):29–36
Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA et al (2009) 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 85(12):1089–1100
Moulder JE, Fish BL, Holcenberg JS, Sun GX (1990) Hepatic function and drug pharmacokinetics after total body irradiation plus bone marrow transplant. Int J Radiat Oncol Biol Phys 19:1389–1396
Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmoud J et al (2011) Salen Mn complexes mitigate radiation injury in normal tissues. Anti-Cancer Agents Med Chem 11(4):359–371
McCarthy ET, Sharma R, Sharma M (2005) Protective effect of 20-hydroxy-eicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 67(1):152–156
Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, Roman RJ (2005) Transforming growth factor-β, 20-HETE interaction, and glomerular injury in Dahl Salt-Sensitive rats. Hypetension 45:1–6
Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB (2006) Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Front Biosci 1(11):968–976
Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ (2002) Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73:366–372
Sharma M, Sharma R, McCarthy ET, Savin VJ (2004) The FSGS permeability factor: biochemical characteristics and biological effects. Exp Biol Med 229:85–98
Sharma M, Sharma R, Ge XL, Fish BL, McCarthy ET, Savin VJ, Cohen EP, Moulder JE (2001) Early detection of radiation-induced glomerular injury by albumin permeability assay. Radiat Res 155:474–480
Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE (2008) The urine proteome as a biomarker of radiation injury. Proteomics Clin Appl 2(7):1065–1086
Yammani RR, Sharma M, Seetharam S, Moulder JE, Seetharam B (2002) Loss of albumin and megalin binding to renal cubilin results in albuminuria in rats exposed to total body irradiation. Am J Physiol Regul Integr Comp Physiol 283(2):R339–R346
Rose BD (1987) Pathophysiology of renal disease. McGraw-Hill Professional, New York, pp 366–368
Prasanna PGS, Blakely WF, Bertho JM, Chute JP, Cohen EP, Goans RE et al (2010) Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res 173(2):245–253
Savin VJ, McCarthy ET, Sharma M (2012) Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis. Kidney Res Clin Pract 31:205–213
Rojas-Palma C, Liland A, Jerstad AN, Etherington G, del Rosario Pérez M, Rahola T et al (2009) TMT HANDBOOK—triage, monitoring and treatment—handbook for management of the public in the event of malevolent use of radiation. Norwegian Radiation Protection Agency, Østerås
Swartz HM, Williams BB, Nicolade RJ, Demidenko E, Flood AB (2011) Overview of biodosimetry for management of unplanned exposures to ionizing radiation. Radiat Meas 46:742–748
Demidenko E, Williams BB, Swartz HM (2009) Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiat Res 171(3):310–319
IAEA (2001) Cytogenetic analysis for radiation dose assessment: a manual. Technical report 405, IAEA, Vienna
ISO (2004) Radiation protection—performance criteria for service laboratories performing biological dosimetry by cytogenetics. ISO 19238:2004, International Organization for Standardization, Geneva
Garty G, Karam A, Brenner DJ (2011) Infrastructure to support ultra high throughput biodosimetry screening after a radiological event. Int J Radiat Biol 87:754–765
IAEA (2002) Use of electron paramagnetic resonance dosimetry with tooth enamel for retrospective dose assessment. TECDOC-1331, IAEA. Vienna
Swartz HM, Burke G, Coey M, Demidenko E, Dong R, Grinberg O, Hilton J, Iwasaki A, Lesniewski P, Schauer DA (2007) In vivo EPR for dosimetry. Radiat Meas 42:1075–1084
Trompier F, Kornak L, Calas C, Romanyukha A, Leblanc B, Mitchell CA, Swartz HM, Clairand I (2007) Protocol for emergency EPR dosimetry in fingernails. Radiat Meas 42:1085–1088
Godfrey-Smith DI, Pass B (1997) A new method for retrospective radiation dosimetry: optically stimulated luminescence in dental enamel. Health Phys 72:744–749
Blakely WF, Prasanna PG, Grace MB, Miller AC (2001) Radiation exposure assessment using cytological and molecular biomarkers. Radiat Prot Dosimetry 97(1):17–23
Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, Ginsburg G, Chao NJ, Nevins JR, Chute JP (2008) Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One 3:e1912
Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, Ashworth A, Bouffler S, Badie C (2011) Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 87(2):115–129
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
Marsit CJ, Eddy K, Kelsey KT (2006) MicroRNA responses to cellular stress. Cancer Res 66:10843–10848
Cha HJ, Seong KM, Bae S, Jung JH, Kim CS, Yang KH, Jin YW, An S (2009) Identification of specific microRNAs responding to low and high dose gamma-irradiation in the human lymphoblast line IM9. Oncol Rep 22(4):863–868
Coy SL, Cheema AK, Tyburski JB, Laiakis EC, Collins SP, Fornace A Jr (2011) Radiation metabolomics and its potential in biodosimetry. Int J Radiat Biol 87(8):802–823
Chen C, Brenner DJ, Brown TR (2011) Identification of urinary biomarkers from X-irradiated mice using NMR spectroscopy. Radiat Res 175(5):622–630
Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, Luecke H, Gonzalez FJ, Idle JR (2011) Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 175(4):473–484
Kortz L, Helmschrodt C, Ceglarek U (2011) Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids. Anal Bioanal Chem 399:2635–2644
Zerefos PG, Aivaliotis M, Baumann M, Vlahou A (2012) Analysis of the urine proteome via a combination of multi‐dimensional approaches. Proteomics—European Consortium. doi:10.1002/pmic.201100212
Thongboonkerd V (2007) Practical points in urinary proteomics. J Proteome Res 6(10):3881–3890
Apweiler R, Aslanidis C, Deufel T, Gerstner A et al (2009) Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med 47(6):724–744
Court M, Selevsek N, Matondo M, Allory Y, Garin J, Masselon CD, Domon B (2011) Toward a standardized urine proteome analysis methodology. Proteomics 11(6):1160–1171
Mirza SP, Olivier M (2008) Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol Genomics 33:3–11
Calligaris D, Villard C, Lafitte D (2011) Advances in top-down proteomics for disease biomarker discovery. J Proteomics 74(7):920–934
Halligan BD, Greene AS (2011) Visualize: a free and open source multifunction tool for proteomics data analysis. Proteomics 11(6):1058–1063
Wu B, Guan Z, Zhao H (2006) Parametric and nonparametric FDR estimation revisited. Biometrics 62:735–744
Ashburner M, Ball CA, Blake JA, Botstein D et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25–29
Harris MA, Clark J, Ireland A, Lomax J et al (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32(Database issue):D258–D261
Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, McIntosh MW, Zhang J, Brentnall TA (2009) Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res 8(2):787–797
Brewis IA, Brennan P (2010) Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol 80:1–44
Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, Tasman N, Sun Z, Nilsson E, Pratt B, Prazen B, Eng JK, Martin DB, Nesvizhskii AI, Aebersold R (2010) A guided tour of the Trans-Proteomic Pipeline. Proteomics 10(6):1150–1159
Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE (2007) The role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res 150:106–115
Sharma M, Halligan BD, Wakim BT, Savin VJ et al (2010) The urine proteome for radiation biodosimetry: effect of total body versus local kidney irradiation. Health Phys 98(2):186–195
Sharma M, McCarthy ET, Sharma R, Fish BL et al (2006) Arachidonic acid metabolites mediate the radiation-induced increase in glomerular albumin permeability. Exp Biol Med (Maywood) 231:99–106
Konvalinka A, Scholey JW, Diamandis EP (2011) Searching for new biomarkers of renal diseases through proteomics. Clin Chem. doi:10.1373/clinchem.2011.165969
Coca SG, Singanamala S, Parikh CR (2011) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. doi:10.1038/ki.2011.379
Bonventre JV (2007) Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 156:213–219
Honore PM, Joannes-Boyau O, Boer W (2007) The early biomarker of acute kidney injury: in search of the Holy Grail. Intensive Care Med 33:1866–1868
Devarajan P (2008) Proteomics for the investigation of acute kidney injury. Contrib Nephrol 160:1–16
Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J (2005) Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579:37–46
Narita T, Sasaki H, Hosoba M, Miura T et al (2004) Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 27:1176–1181
Horvath AJ, Forsyth SL, Coughlin PB (2004) Expression patterns of murine antichymotrypsin-like genes reflect evolutionary divergence at the Serpina3 locus. J Mol Evol 59:488–497
Suzuki Y, Yoshida K, Honda E, Sinohara H (1991) Molecular cloning and sequence analysis of cDNAs coding for guinea pig alpha 1-antiproteinases S and F and contrapsin. J Biol Chem 266:928–932
Burkle A (2001) Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 163:1–5
Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18:7644–7655
Kriengsinyos W, Rafii M, Wykes LJ, Ball RO, Pencharz PB (2002) Long-term effects of histidine depletion on whole-body protein metabolism in healthy adults. J Nutr 132:3340–3348
Uchida K, Kawakishi S (1993) 2-Oxo-histidine as a novel biological marker for oxidatively modified proteins. FEBS Lett 332:208–210
Moulder JE (2002) Report on an interagency workshop on the radiobiology of nuclear terrorism. Radiat Res 158(1):118–124
Moulder JE, Medhora M (2011) Advances in mitigation of injuries from radiological terrorism or nuclear accidents. Defence Sci J 61(2):99–104
Pellmar TC, Rockwell S (2005) Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 163(1):115–123
Brown SL, Kolozsvary A, Liu J, Jenrow KA, Ryu S, Kim JH (2010) Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat Res 173(4):462–468
MacVittie TJ, Farese AM, Jackson W (2005) Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys 89(5):546–555
Epperly MW, Wang H, Jones JA, Dixon T, Montesinos CA, Greenberger JS (2011) Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. Radiat Res 175(6):759–765
Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE et al (2009) Renin-angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys 75(5):1528–1536
Jenrow KA, Brown SL, Liu J, Kolozsvary A, Kim JH (2010) Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus. Radiat Oncol 5(1):Article 6
Cohen EP, Bedi M, Irving AA, Jacobs ER, Tomic R, Klein JP et al (2012) Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Phys 83(1):292–296
Moulder JE, Robbins MEC, Cohen EP, Hopewell JW, Ward WF (1998) Pharmacologic modification of radiation-induced late normal tissue injury. Cancer Treat Res 93:129–151
Bertho JM, Roy L, Souidi M, Benderitter M, Gueguen Y, Lataillade JJ et al (2008) New biological indicators to evaluate and monitor radiation-induced damage: an accident case report. Radiat Res 169(5):543–550
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sharma, M., Moulder, J.E. (2013). The Urine Proteome as a Radiation Biodosimeter. In: Leszczynski, D. (eds) Radiation Proteomics. Advances in Experimental Medicine and Biology, vol 990. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5896-4_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-5896-4_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5895-7
Online ISBN: 978-94-007-5896-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)